CTRI/2022/02/040186尚未招募2 期
Role of Rituximab in maintaining long term remission of idiopathic steroid dependent and steroid resistant nephrotic syndrpme - RITUXIMAINS
Dr Arpita Raychaudhury0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Patients with idiopathic nephrotic syndrome with steroid
- •dependence or frequent relapses who has failed at least one steroid
- •sparing agent.
- •2) Secondary steroid resistant nephrotic syndrome with return of steroid sensitivity during treatment of relapse,failing at leat one immunosuppressant other than steroid.
- •3) In remission state or 24 hr urine protein < 1gm
- •4) Those who have given informed written consent
排除标准
- •1) Primary steroid resistant nephrotic syndrome
- •2) Secondary cause of nephrotic syndrome
- •3) Genetic cause of nephrotic syndrome 4) Hepatitis B and C serology positive
- •5) Acute or chronic active infection
- •6) Chronic lung disease or uncontrolled asthma
- •7) Leucopenia or thrombocytopenia
- •8) ALT/AST >2.5 times upper limit of normal
- •9) Expected rituximab first infusion date less than 4 weeks from a live
- •vaccination
- •10) Regular follow-up not feasible
研究者
相似试验
Unknown
3 期
Rituximab Maintenance Therapy in Aggressive CD20 (Cluster of Differentiation Antigen 20) Positive Lymphoma and Mantle Cell LymphomaCD20+ Aggressive Lymphoma, Mantle Cell LymphomaNCT01933711University Hospital Heidelberg328
进行中（未招募）
1 期
Maintenance treatment With rituximab in ITPImmune thrombocytopeniaEUCTR2015-005276-14-DKSykehuset Østfold HF130
已完成
3 期
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)Chronic Lymphocytic LeukemiaNCT01118234Arbeitsgemeinschaft medikamentoese Tumortherapie256
已完成
3 期
The PROLONG Trial - Rituximab Maintenance Therapy in ITPPurpura, Thrombocytopenic, IdiopathicNCT03010202Ostfold Hospital Trust136
已完成
2 期
Rituximab in treatment of Rheumatoid arthritis in Indian patientsCTRI/2017/08/009321CENTER FOR RHEUMATIC DISEASES60